About Cerluten
CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration.
A short peptide bioregulator derived from brain and CNS tissue, developed by the Khavinson Institute. Studied for cognitive support, neuroprotection, and mitigation of age-related cognitive decline.
Research Areas
Regulatory & Evidence
Risk Profile
Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.
Regulatory Status
- Availability Status
- Research Only
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Safety Notes
Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.
Reported contraindications & considerations
Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.
Where to Find Cerluten
1 providerClinics
1 providerFrequently Asked Questions — Cerluten
A short peptide bioregulator derived from brain and CNS tissue, developed by the Khavinson Institute. Studied for cognitive support, neuroprotection, and mitigation of age-related cognitive decline.
neuroprotection, cognitive support, memory, anti-aging, longevity.
1 provider in the directory currently offers Cerluten.